GeneDx Holdings (WGS) Treasury Shares (2021 - 2026)

GeneDx Holdings (WGS) has 6 years of Treasury Shares data on file, last reported at $1.7 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.7 million, down 8.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 8.06% YoY), and the FY2025 annual result was $1.5 million, down 18.71% from the prior year.
• Treasury Shares rose to $1.7 million in Q1 2026 per WGS's latest filing, from $1.5 million in the prior quarter.
• Over five years, Treasury Shares peaked at $23.7 million in Q3 2022 and troughed at $855061.0 in Q4 2022.
• A 5-year average of $4.9 million and a median of $1.8 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 93.21% in 2022, then jumped 76.35% in 2023.
• A 5-year view of Treasury Shares shows it stood at $855061.0 in 2022, then jumped by 76.35% to $1.5 million in 2023, then grew by 23.99% to $1.9 million in 2024, then slipped by 18.71% to $1.5 million in 2025, then rose by 8.72% to $1.7 million in 2026.
• Business Quant data shows WGS's Treasury Shares at $1.7 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.